Originally posted on August 2, 2023 @ 07:21 Grünenthal GmbH and Kyowa Kirin Co., Ltd. have today announced the successful completion of a joint venture collaboration for Kyowa Kirin International’s established medicines portfolio. The portfolio, which comprises 13 brands across six therapeutic areas primarily focused on pain management, includes Abstral® and PecFent® for breakthrough cancer pain…
No responses yet